A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation
The influenza A virus (IAV), renowned for its high contagiousness and potential to catalyze global pandemics, poses significant challenges due to the emergence of drug-resistant strains. Given the critical role of RNA polymerase in IAV replication, it stands out as a promising target for anti-IAV th...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Acta Pharmaceutica Sinica B |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S221138352500365X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849233569546764288 |
|---|---|
| author | Kunyu Lu Jianfu He Chongjun Hong Haowei Li Jiaai Ruan Jinshen Wang Haoxing Yuan Binhao Rong Chan Yang Gaopeng Song Shuwen Liu |
| author_facet | Kunyu Lu Jianfu He Chongjun Hong Haowei Li Jiaai Ruan Jinshen Wang Haoxing Yuan Binhao Rong Chan Yang Gaopeng Song Shuwen Liu |
| author_sort | Kunyu Lu |
| collection | DOAJ |
| description | The influenza A virus (IAV), renowned for its high contagiousness and potential to catalyze global pandemics, poses significant challenges due to the emergence of drug-resistant strains. Given the critical role of RNA polymerase in IAV replication, it stands out as a promising target for anti-IAV therapies. In this study, we identified a novel C-3-substituted oleanolic acid benzyl amide derivative, A5, as a potent inhibitor of the PAC–PB1N polymerase subunit interaction, with an IC50 value of 0.96 ± 0.21 μmol/L. A5 specifically targets the highly conserved PAC domain and demonstrates remarkable efficacy against both laboratory-adapted and clinically isolated IAV strains, including multidrug-resistant strains, with EC50 values ranging from 0.60 to 1.83 μmol/L. Notably, when combined with oseltamivir, A5 exhibits synergistic effects both in vitro and in vivo. In a murine model, dose-dependent administration of A5 leads to a significant reduction in IAV titers, resulting in a high survival rate among treated mice. Additionally, A5 treatment inhibits virus-induced Toll-like receptor 4 activation, attenuates cytokine responses, and protects against IAV-induced inflammatory responses in macrophages. In summary, A5 emerges as a novel inhibitor with high efficiency and broad-spectrum anti-influenza activity. |
| format | Article |
| id | doaj-art-bb92bd13107545d49bfb83c9f673b830 |
| institution | Kabale University |
| issn | 2211-3835 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Acta Pharmaceutica Sinica B |
| spelling | doaj-art-bb92bd13107545d49bfb83c9f673b8302025-08-20T05:06:31ZengElsevierActa Pharmaceutica Sinica B2211-38352025-08-011584156417310.1016/j.apsb.2025.05.031A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammationKunyu Lu0Jianfu He1Chongjun Hong2Haowei Li3Jiaai Ruan4Jinshen Wang5Haoxing Yuan6Binhao Rong7Chan Yang8Gaopeng Song9Shuwen Liu10Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, ChinaGuangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, ChinaKey Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Energy, South China Agricultural University, Guangzhou 510642, ChinaGuangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, ChinaKey Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Energy, South China Agricultural University, Guangzhou 510642, ChinaGuangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, ChinaGuangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, ChinaGuangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, ChinaThe Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Southern Medical University, Dongguan 523018, China; MOE Key Laboratory of Infectious Diseases Research in South China, Southern Medical University, Guangzhou 510515, China; Corresponding authors.Key Laboratory for Biobased Materials and Energy of Ministry of Education, College of Materials and Energy, South China Agricultural University, Guangzhou 510642, China; Corresponding authors.Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory of Drug Metabolism Research and Evaluation, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China; State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology, Southern Medical University, Guangzhou 510515, China; The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Southern Medical University, Dongguan 523018, China; MOE Key Laboratory of Infectious Diseases Research in South China, Southern Medical University, Guangzhou 510515, China; Corresponding authors.The influenza A virus (IAV), renowned for its high contagiousness and potential to catalyze global pandemics, poses significant challenges due to the emergence of drug-resistant strains. Given the critical role of RNA polymerase in IAV replication, it stands out as a promising target for anti-IAV therapies. In this study, we identified a novel C-3-substituted oleanolic acid benzyl amide derivative, A5, as a potent inhibitor of the PAC–PB1N polymerase subunit interaction, with an IC50 value of 0.96 ± 0.21 μmol/L. A5 specifically targets the highly conserved PAC domain and demonstrates remarkable efficacy against both laboratory-adapted and clinically isolated IAV strains, including multidrug-resistant strains, with EC50 values ranging from 0.60 to 1.83 μmol/L. Notably, when combined with oseltamivir, A5 exhibits synergistic effects both in vitro and in vivo. In a murine model, dose-dependent administration of A5 leads to a significant reduction in IAV titers, resulting in a high survival rate among treated mice. Additionally, A5 treatment inhibits virus-induced Toll-like receptor 4 activation, attenuates cytokine responses, and protects against IAV-induced inflammatory responses in macrophages. In summary, A5 emerges as a novel inhibitor with high efficiency and broad-spectrum anti-influenza activity.http://www.sciencedirect.com/science/article/pii/S221138352500365XInfluenza A virusRNA polymeraseProtein–protein interactionPentacyclic triterpenoidsOleanolic acid amide derivativesDrug-resistant strains |
| spellingShingle | Kunyu Lu Jianfu He Chongjun Hong Haowei Li Jiaai Ruan Jinshen Wang Haoxing Yuan Binhao Rong Chan Yang Gaopeng Song Shuwen Liu A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation Acta Pharmaceutica Sinica B Influenza A virus RNA polymerase Protein–protein interaction Pentacyclic triterpenoids Oleanolic acid amide derivatives Drug-resistant strains |
| title | A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation |
| title_full | A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation |
| title_fullStr | A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation |
| title_full_unstemmed | A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation |
| title_short | A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA–PB1 interactions and modulating host macrophage inflammation |
| title_sort | novel c 3 substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza a by targeting pa pb1 interactions and modulating host macrophage inflammation |
| topic | Influenza A virus RNA polymerase Protein–protein interaction Pentacyclic triterpenoids Oleanolic acid amide derivatives Drug-resistant strains |
| url | http://www.sciencedirect.com/science/article/pii/S221138352500365X |
| work_keys_str_mv | AT kunyulu anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT jianfuhe anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT chongjunhong anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT haoweili anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT jiaairuan anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT jinshenwang anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT haoxingyuan anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT binhaorong anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT chanyang anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT gaopengsong anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT shuwenliu anovelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT kunyulu novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT jianfuhe novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT chongjunhong novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT haoweili novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT jiaairuan novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT jinshenwang novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT haoxingyuan novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT binhaorong novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT chanyang novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT gaopengsong novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation AT shuwenliu novelc3substitutedoleanolicacidbenzylamidederivativeexhibitstherapeuticpotentialagainstinfluenzaabytargetingpapb1interactionsandmodulatinghostmacrophageinflammation |